Skip to content

Clinical trials

Leukemia, B-Cell trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, B-Cell Phase: Not applicable Country / region: China Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20181
20201
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hebei Senlang Biotechnology Inc., Ltd.1
Innovative Cellular Therapeutics Co., Ltd.1
Kang YU1
Qingdao Central Hospital1
Shenzhen Geno-Immune Medical Institute1
Zhu Xiaofan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, B-Cell6
Lymphoma, B-Cell4
Carcinoma, Hepatocellular1
Leukemia1
Leukemia, T-Cell1
Lymphoma1
Multiple Myeloma1
Neoplasm, Residual1
Neoplasms, Plasma Cell1
Pancreatic Neoplasms1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.